Free Trial
NYSEAMERICAN:VNRX

VolitionRX (VNRX) Stock Price, News & Analysis

VolitionRX logo
$0.68 +0.02 (+2.55%)
As of 04:10 PM Eastern

About VolitionRX Stock (NYSEAMERICAN:VNRX)

Key Stats

Today's Range
$0.66
$0.71
50-Day Range
$0.42
$0.92
52-Week Range
$0.40
$0.94
Volume
121,375 shs
Average Volume
202,648 shs
Market Capitalization
$71.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

VolitionRX Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

VNRX MarketRank™: 

VolitionRX scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for VolitionRX.

  • Earnings Growth

    Earnings for VolitionRX are expected to grow in the coming year, from ($0.50) to ($0.33) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of VolitionRX is -2.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of VolitionRX is -2.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about VolitionRX's valuation and earnings.
  • Percentage of Shares Shorted

    0.84% of the float of VolitionRX has been sold short.
  • Short Interest Ratio / Days to Cover

    VolitionRX has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in VolitionRX has recently increased by 331.34%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    VolitionRX does not currently pay a dividend.

  • Dividend Growth

    VolitionRX does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.84% of the float of VolitionRX has been sold short.
  • Short Interest Ratio / Days to Cover

    VolitionRX has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in VolitionRX has recently increased by 331.34%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    1 people have searched for VNRX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, VolitionRX insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.40% of the stock of VolitionRX is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 8.09% of the stock of VolitionRX is held by institutions.

  • Read more about VolitionRX's insider trading history.
Receive VNRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VolitionRX and its competitors with MarketBeat's FREE daily newsletter.

VNRX Stock News Headlines

Q1 2025 VolitionRX Ltd Earnings Call Transcript
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
VolitionRX Q1 2025 Earnings Preview
See More Headlines

VNRX Stock Analysis - Frequently Asked Questions

VolitionRX's stock was trading at $0.58 at the start of the year. Since then, VNRX stock has increased by 18.2% and is now trading at $0.6858.

VolitionRX Limited (NYSEAMERICAN:VNRX) issued its quarterly earnings data on Wednesday, November, 10th. The medical research company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.11) by $0.02. The medical research company had revenue of $0.03 million for the quarter, compared to analyst estimates of $0.03 million.

Shares of VNRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that VolitionRX investors own include Chesapeake Energy (CHKAQ), Bausch Health Cos (BHC), Avino Silver & Gold Mines (ASM), Exelixis (EXEL), T2 Biosystems (TTOO), Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX).

Company Calendar

Last Earnings
11/10/2021
Today
7/14/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:VNRX
Previous Symbol
NYSEMKT:VNRX
CIK
93314
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.56)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.97 million
Net Margins
-1,835.37%
Pretax Margin
-1,853.55%
Return on Equity
N/A
Return on Assets
-220.07%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.40
Quick Ratio
0.40

Sales & Book Value

Annual Sales
$1.23 million
Price / Sales
58.33
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.28) per share
Price / Book
-2.46

Miscellaneous

Outstanding Shares
103,980,000
Free Float
93,168,000
Market Cap
$71.75 million
Optionable
Not Optionable
Beta
1.20
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSEAMERICAN:VNRX) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners